Found: 5
Select item for more details and to access through your institution.
2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Psychosocial care for patients and their families is integral to supportive care in cancer: MASCC position statement.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer.
- Published in:
- Supportive Care in Cancer, 2007, v. 15, n. 11, p. 1293
- By:
- Publication type:
- Article
Perceptions of masculinity and self-image in adolescent and young adult testicular cancer survivors: implications for romantic and sexual relationships.
- Published in:
- Psycho-Oncology, 2011, v. 20, n. 7, p. 738, doi. 10.1002/pon.1772
- By:
- Publication type:
- Article